|
Home:
Web Guide 2: Christopher
Twelves, MD: Selected references
Selected references
Abushullaih S et al. Incidence and severity of hand-foot
syndrome in colorectal cancer patients treated with capecitabine:
A single-institution experience. Cancer Invest 2002;20(1):3-10.
Abstract
Borner M et al. Answering patients' needs: Oral alternatives
to intravenous therapy. Oncologist 2001;6 Suppl 4:12-6.
Abstract
Cassata A et al. Capecitabine: Indications and future
perspectives in the treatment of metastatic colorectal and breast
cancer. Tumori 2001;87(6):364-71. Abstract
Cunningham D, James RD. Integrating the oral fluoropyrimidines
into the management of advanced colorectal cancer. Eur
J Cancer 2001;37(7):826-34. Abstract
Hoff PM et al. Comparison of oral capecitabine versus
intravenous fluorouracil plus leucovorin as first-line treatment
in 605 patients with metastatic colorectal cancer: Results of a
randomized phase III study. J Clin Oncol 2001;19(8):2282-92.
Abstract
Lin EH et al. Celecoxib attenuated capecitabine-induced
hand-and-foot syndrome (HFS) and diarrhea and improved time to tumor
progression in metastatic colorectal cancer (MCRC). Proc
ASCO 2002;Abstract
2364.
Marshall JL. Capecitabine in colorectal cancer.
Oncology (Huntingt) 2001;15(1 Suppl 2):41-6; discussion 46-7. Abstract
McGavin JK, Goa KL. Capecitabine: A review of its use
in the treatment of advanced or metastatic colorectal cancer.
Drugs 2001;61(15):2309-26. Abstract
Seitz JF. 5-fluorouracil/leucovorin versus capecitabine
in patients with stage III colon cancer. Semin Oncol 2001;28(1
Suppl 1):41-4. Abstract
Tabernero J et al. Capecitabine and oxaliplatin in combination
(Xelox) as first-line therapy for patients (pts) with metastatic
colorectal cancer (MCRC): Results of an international multicenter
phase II trial. Proc ASCO 2002;Abstract
531.
Twelves CJ, Cassidy J. Which endpoints should we use in
evaluating the use of novel fluoropyrimidine regimens in colorectal
cancer? Br J Cancer 2002;86(11):1670-6. Abstract
Van Cutsem E et al. Oral capecitabine compared with intravenous
fluorouracil plus leucovorin in patients with metastatic colorectal
cancer: Results of a large phase III study. J Clin Oncol
2001;19(21):4097-106. Abstract
Zeuli M et al. Capecitabine and oxaliplatin in advanced
colorectal cancer: A dose-finding study. Ann Oncol 2001;12(12):1737-41.
Abstract
|
